Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
PHASE3
BEAT Tuberculosis is a phase 3, open label, multi-centre, randomized contro...
Treatment Shortening of MDR-TB Using Existing and New Drugs
PHASE2
The purpose of this study is to compare the efficacy of a 'new treatment re...
Status
Completed
Location
Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis
PHASE2
This study measured the early bactericidal activity (EBA), safety, tolerabi...